Vanda Pharmaceuticals Inc.
VNDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19 | $3 | $6 | $33 |
| Dep. & Amort. | $8 | $3 | $3 | $3 |
| Deferred Tax | -$6 | -$1 | $1 | $7 |
| Stock-Based Comp. | $12 | $14 | $0 | $0 |
| Change in WC | -$7 | -$1 | $6 | $3 |
| Other Non-Cash | -$4 | -$5 | $16 | $19 |
| Operating Cash Flow | -$16 | $13 | $32 | $64 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | -$4 | -$101 | $0 | $0 |
| Inv. Purchases | -$365 | -$513 | -$349 | -$420 |
| Inv. Sales/Matur. | $352 | $602 | $400 | $344 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$17 | -$12 | $50 | -$77 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $4 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$0 | $0 | $1 | $4 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$34 | $1 | $83 | -$9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $136 | $135 | $52 | $61 |
| End Cash | $103 | $136 | $135 | $52 |
| Free Cash Flow | -$16 | $12 | $31 | $64 |